CAPTRUST Financial Advisors
GRNA

CAPTRUST Financial Advisors’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

CAPTRUST Financial Advisors’s Portfolio GRNA Stock Details GRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-817
Closed -$2K – 4427
2022
Q2 		$2K Buy
+817
New +$5.67K ﹤0.01% 4557

Other funds holding GRNA

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
CGC
Continental Grain Company New York $366M AUM 0.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
TCM
Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

CAPTRUST Financial Advisors's GRNA Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2022, closing a stake of 817 shares — an estimated $2K sold.

CAPTRUST Financial Advisors first reported a position in GRNA in Q2 2022 and held it in 1 quarter. The position peaked at $2K in Q2 2022. 57 funds tracked by Wall St. Rank hold GRNA as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 817 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2022, an estimated $2K.
  • CAPTRUST Financial Advisors first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q2 2022 and held it in 1 quarter.
  • CAPTRUST Financial Advisors's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $2K in Q2 2022.
  • 57 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.